Clinical Trial Update: MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MOD-4023 (long-lasting human growth hormone) in adults with growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• MOD-4023 (long-acting growth hormone)

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: COMPLETED